Effects of Overnight Low Oxygen Exposure on Energy Balance

NCT ID: NCT04151927

Last Updated: 2021-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-11

Study Completion Date

2021-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research study will evaluate changes in resting metabolic rate, appetite, and heart rate variability following overnight exposure (8 h/night) to normobaric hypoxia (NH) or normobaric normoxic (NN). In randomized order, participants will sleep one night in NH conditions (\~15% oxygen; achieved with nitrogen dilution, equivalent to \~8500 feet elevation) and another night in NN (control) conditions (\~20% oxygen; achieved with nitrogen dilution, equivalent to \~1000 feet elevation).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Weight loss is a common factor reported in lowlanders traveling to high altitudes. Although the exact cause is unknown, studies have shown that weight loss at high altitude is associated with the amount of time and severity of the altitude exposure. Upon arrival to high altitude (≥ 5000 feet), numerous physiological adaptations occur that may promote weight loss, such as increased energy expenditure and reduced appetite. The breadth of current altitude research is limited by the logistical and monetary constraints of traveling to remote locations or access to an altitude chamber. A more logistically feasible alternative is the simulation of low oxygen conditions at sea level, using a commercially available tent and generator system to reduce ambient oxygen concentrations. The current research study will evaluate changes in resting metabolic rate, appetite, and heart rate variability following overnight exposure (8 h/night) to normobaric hypoxia (NH) or normobaric normoxic (NN). In randomized order, participants will sleep one night in NH conditions (\~15% oxygen; achieved with nitrogen dilution, equivalent to \~8500 feet elevation) and another night in NN (control) conditions (\~20% oxygen; achieved with nitrogen dilution, equivalent to \~1000 feet elevation). In the morning, following NH or NN exposure, resting metabolic rate will be measured using indirect calorimetry, appetite using an ad libitum buffet meal protocol, and heart rate variability by electrocardiogram. It is hypothesized that exposure to overnight NH will result in increased resting metabolic rate, decreased appetite, and decreased heart rate variability.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Resting Metabolic Rate Appetite Heart Rate Variability

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

High altitude Metabolic adaptations Energy balance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normobaric Hypoxia (NH)

Overnight exposure (8 hours) to NH conditions (\~15% oxygen; achieved with nitrogen dilution, equivalent to \~8500 feet elevation) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY).

Group Type EXPERIMENTAL

Normobaric Hypoxia

Intervention Type DEVICE

Low oxygen exposure to mimic \~8500 feet elevation.

Normobaric Normoxia

Intervention Type DEVICE

Normal oxygen exposure to mimic \~1000 feet elevation (sham comparator).

Normobaric Normoxia (NN)

Overnight exposure (8 hours) to NN conditions (\~20% oxygen; achieved with nitrogen dilution, equivalent to \~1000 feet elevation) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY).

Group Type SHAM_COMPARATOR

Normobaric Hypoxia

Intervention Type DEVICE

Low oxygen exposure to mimic \~8500 feet elevation.

Normobaric Normoxia

Intervention Type DEVICE

Normal oxygen exposure to mimic \~1000 feet elevation (sham comparator).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Normobaric Hypoxia

Low oxygen exposure to mimic \~8500 feet elevation.

Intervention Type DEVICE

Normobaric Normoxia

Normal oxygen exposure to mimic \~1000 feet elevation (sham comparator).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged 20 - 45 years
* Body mass index between 18.5 - 24.5 kg/m2
* Born at altitudes less than 2,100 meters (\~7,000 feet)
* Currently residing in Tallahassee, Florida or the surrounding area
* Not taking any medication(s) that interfere with metabolism or oxygen delivery/transport for four weeks before and throughout the entire study (e.g., includes sedatives, sleeping aids, tranquilizers, and/or any medication that depresses ventilation, diuretics, alpha, and beta-blockers).
* Willing to refrain from smoking, vaping, chewing tobacco, and dietary supplement use throughout the entire study
* Willing to spend two overnight visits on the Florida State University campus.

Exclusion Criteria

* Living in areas that are more than 1,200 m (\~4,000 feet), or have traveled to areas that are more than 1,200 m for five days or more within the last two months
* Metabolic or cardiovascular abnormalities, gastrointestinal disorders, or any condition that interferes with metabolism or oxygen delivery/transport (e.g., kidney disease, diabetes, cardiovascular disease, etc.)
* Prior diagnosis of apnea or other sleeping disorders
* Prior diagnosis of high-altitude pulmonary edema or high-altitude cerebral edema
* Prior diagnosis of anemia or sickle cell anemia/trait
* Present condition of alcoholism, anabolic steroid, or other substance abuse issues
* Women who are pregnant, lactating, planning to become pregnant, or who have had an irregular menstrual cycle in the past six months.
* Allergies or intolerance to foods included in the standardized or ad libitum meal (e.g., lactose intolerance/milk allergy)
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Florida State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Claire E. Berryman

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claire E Berryman, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Nutrition, Food, and Exercise Science at Florida State University.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Florida State University

Tallahassee, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY00000184

Identifier Type: -

Identifier Source: org_study_id